Table 5.

Median times (and interquartile range) for imaging and to treatment in recent positive acute stroke clinical trials, in minutes

	MR CLEAN	EXTEND-IA	ESCAPE	SWIFT PRIME	REVASCAT	THERAPY
Multimodal CT acquisition time	n/a	6min28s (range: 3min37s-9min0sec)	n/a	8 (4–21)	n/a	n/a
PCT post-processing time	n/a	5min20s (range: 3–10min)	n/a	3.9 (2.2–5.4)	n/a	n/a
Multimodal MR acquisition time	n/a	n/a	n/a	12 (7–15)	n/a	n/a
PWI/DWI post-processing time	n/a	n/a	n/a	2 (1.5–2.7)	n/a	n/a
“Door-to-Arterial Access” time, min
for entire IA cohort	n/a	109 (78–150)	76 (62–108)	90 (69–120)	109 (85–163)	142 (85–179.5)
for patients selected based on NCCT alone	n/a	n/a	n/a	n/a	n/a	96.5 (83.5–128.5) (n=4)
for patients selected based on NCCT+CTA	n/a	n/a	76 (62–108)	84 (55–102)	108.0 (85–163)	150.5 (121.5–200.5) (n=28)
for patients selected based on NCCT+CTA+PCT	n/a	109 (78–150)	n/a	90 (69–112)	103.0 (76–136)	101 (68–160) (n=18)
for patients selected based on MRI	n/a	n/a	n/a	84 (55–102)	114.0 (94–155)	114.5 (56–173) (n=2)